ImmunoGenesis Funding & Investors
ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.
immunogenesis.comTotal Amount Raised: $28,000,000
ImmunoGenesis Funding Rounds
Series Unknown
$4,500,000
Series Unknown Investors
Cancer Focus FundSeed
$8,000,000
Seed Investors
Juno CapitalGrant
$15,500,000
Grant Investors
Cancer Prevention & Research Institute of Texas
Funding info provided by Diffbot.